FOXC1 and FOXC2 Ablation Causes Abnormal Valvular Endothelial Cell Junctions and Lymphatic Vessel Formation in Myxomatous Mitral Valve Degeneration
Can Tan,Zhi-Dong Ge,Shreya Kurup,Yaryna Dyakiv,Ting Liu,William A Muller,Tsutomu Kume,Can TanZhi-Dong GeShreya KurupYaryna DyakivTing LiuWilliam A. MullerTsutomu KumeDepartment of Medicine,Feinberg Cardiovascular and Renal Research Institute,Feinberg School of Medicine,Northwestern University,Chicago,IL. (C.T.,S.K.,Y.D.,T.L.,T.K.)Departments of Pediatrics,Surgery,and Pathology,Cardiovascular-Thoracic Surgery and the Heart Center,Stanley Manne Children's Research Institute,Ann & Robert H. Lurie Children's Hospital of Chicago,Feinberg School of Medicine,Northwestern University,Chicago,IL. (Z.-D.G.)Department of Pathology,Feinberg School of Medicine,Northwestern University,Chicago,IL. (W.A.M.)Honors College,University of Illinois at Chicago (S.K.).
DOI: https://doi.org/10.1161/atvbaha.124.320316
2024-07-12
Arteriosclerosis Thrombosis and Vascular Biology
Abstract:Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print. BACKGROUND:Mitral valve (MV) disease including myxomatous degeneration is the most common form of valvular heart disease with an age-dependent frequency. Genetic evidence indicates that mutations of the transcription factorFOXC1are associated with MV defects, including MV regurgitation. In this study, we sought to determine whether murineFoxc1and its closely related factor,Foxc2, are required in valvular endothelial cells (VECs) for the maintenance of MV leaflets, including VEC junctions and the stratified trilaminar ECM (extracellular matrix).METHODS:Adult mice carrying tamoxifen-inducible, vascular endothelial cell (EC), and lymphatic EC–specific, compoundFoxc1;Foxc2mutations (ie, EC-Foxc-DKO and lymphatic EC-Foxc-DKO mice, respectively) were used to study the function ofFoxc1andFoxc2in the maintenance of MVs. The EC and lymphatic EC mutations ofFoxc1/c2were induced at 7 to 8 weeks of age by tamoxifen treatment, and abnormalities in the MVs of these mutant mice were assessed via whole-mount immunostaining, immunohistochemistry/RNAscope, Movat pentachrome/Masson Trichrome staining, and Evans blue injection.RESULTS:EC deletions ofFoxc1andFoxc2in mice resulted in abnormally extended and thicker MVs by causing defects in the regulation of ECM organization with increased proteoglycan and decreased collagen. Notably, reticular adherens junctions were found in VECs of control MV leaflets, and these reticular structures were severely disrupted in EC-Foxc-DKO mice. PROX1 (prospero homeobox protein 1), a key regulator in a subset of VECs on the fibrosa side of MVs, was downregulated in EC-Foxc1/c2mutant VECs. Furthermore, we determined the precise location of lymphatic vessels in murine MVs, and these lymphatic vessels were aberrantly expanded and dysfunctional in EC-Foxc1/c2mutant MVs. Lymphatic EC deletion ofFoxc1/c2also resulted in similar structural/ECM abnormalities as seen in EC-Foxc1/c2mutant MVs.CONCLUSIONS:Our results indicate thatFoxc1andFoxc2are required for maintaining the integrity of the MV, including VEC junctions, ECM organization, and lymphatic vessel formation/function to prevent myxomatous MV degeneration.
peripheral vascular disease,hematology